Showing results (631-640 of 1,502) with videos related to

Sort By:
Pageof 151
Cancer Letters|March 23, 1995
Is episialin/MUC1 involved in breast cancer progression?J Hilkens, H L Vos, J Wesseling, et al.
European Journal of Radiology|November 14, 2013
Avoiding preoperative breast MRI when conventional imaging is sufficient to stage patients eligible for breast conserving therapyKenneth E Pengel, Claudette E Loo, Jelle Wesseling, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Captopril-induced increase in coronary flow: an SH-dependent effect on arachidonic acid metabolism?W H van Gilst, J van Wijngaarden, E Scholtens, et al.
International Review of Neurobiology|November 5, 2011
Behavioral and molecular biomarkers in translational animal models for neuropsychiatric disordersZoltán Sarnyai, Murtada Alsaif, Sabine Bahn, et al.
Journal of Ethnopharmacology|June 1, 2019
Hazard assessment of Maerua subcordata (Gilg) DeWolf. for selected endpoints using a battery of in vitro testsMebrahtom Gebrelibanos Hiben, Lenny Kamelia, Laura de Haan, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Drug use in pregnancy: a comparative appraisal of data collecting methodsL T de Jong-van den Berg, C M Waardenburg, F M Haaijer-Ruskamp, et al.
Aging Clinical and Experimental Research|April 13, 2006
Early nutritional supplementation immediately after diagnosis of infectious disease improves body weight in psychogeriatric nursing home residentsWendeline Wouters-Wesseling, Erika Slump, Chantal N Kleijer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 15, 2013
A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathologyHendrik Wesseling, Man K Chan, T M Tsang, et al.
The American Journal of Medicine|March 11, 1988
Protective effects of captopril against ischemia/reperfusion-induced ventricular arrhythmias in vitro and in vivoP A deGraeff, C D deLangen, W H van Gilst, et al.
Molecular Cancer Therapeutics|December 6, 2015
High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast CancerPhilip C Schouten, Marieke A Vollebergh, Mark Opdam, et al.
Pageof 151